Weber G, Reardon M
Adv Enzyme Regul. 1986;25:65-83. doi: 10.1016/0065-2571(86)90008-7.
Evidence was provided that in rat liver synthase II activity, amount and turnover were regulated primarily by insulin. When rats were starved, synthase II activity and the immunotitratable enzyme amount markedly decreased; refeeding restored enzyme activity and amount to normal range. The changes in activity and amount were paralleled with alterations in the level of circulating insulin in the plasma. When starved rats were treated with anti-insulin serum before and during refeeding, the animals consumed the food, but the rise in synthase II activity was prevented. In diabetic rats, the activity and amount of synthase II in the liver markedly decreased and insulin treatment restored them to normal range. Actinomycin treatment prevented the refeeding and the insulin-induced rise in synthase II activity and amount. Study of the turnover of synthase II showed that in starvation the rate of synthesis decreased and refeeding restored the enzyme synthetic and degradation rates to normal range. In the diabetic rat, synthase II synthetic rate markedly decreased, and the degradation rate increased. Insulin returned the synthetic and catabolic rates to normal livers. In rapidly growing rat hepatoma 3924A, synthase II activity and amount were elevated 9- to 10-fold. Turnover studies showed that the synthetic rate in hepatoma 3924A was approximately 10-fold higher than that of normal liver. The catabolic rates of synthase II were similar in the liver and hepatoma. Thus, the increased activity and amount of synthase II in the hepatoma was due primarily to an increased rate of enzyme biosynthesis. Evidence was presented that in starvation and diabetes and on refeeding and insulin administration there is very little or no change in the enzymic activity, amount and turnover of hepatoma synthase II. The marked contrast between the turnover rate of hepatoma 3924A synthase II activity and that of the normal liver enzyme in starvation and in diabetes is under investigation. This overview of the behavior of activity, amount and turnover of synthase II in liver and hepatoma 3924A provides evidence of the important role of insulin in regulation of liver synthase II and of the apparent lack of responsiveness of the hepatoma enzyme to insulin concentrations. The precise details of the experimental procedures and the enzymic results will be published elsewhere.
有证据表明,在大鼠肝脏中,合成酶II的活性、含量及周转率主要受胰岛素调节。大鼠饥饿时,合成酶II的活性及免疫滴定法测定的酶含量显著降低;重新喂食后,酶活性和含量恢复至正常范围。活性和含量的变化与血浆中循环胰岛素水平的改变平行。饥饿大鼠在重新喂食前及喂食期间用抗胰岛素血清处理后,动物进食,但合成酶II活性的升高受到抑制。在糖尿病大鼠中,肝脏中合成酶II的活性和含量显著降低,胰岛素治疗可使其恢复至正常范围。放线菌素处理可阻止重新喂食及胰岛素诱导的合成酶II活性和含量升高。对合成酶II周转率的研究表明,饥饿时合成速率降低,重新喂食可使酶的合成和降解速率恢复至正常范围。在糖尿病大鼠中,合成酶II的合成速率显著降低,降解速率升高。胰岛素可使正常肝脏的合成和分解代谢速率恢复正常。在快速生长的大鼠肝癌3924A中,合成酶II的活性和含量升高了9至10倍。周转率研究表明,肝癌3924A中的合成速率比正常肝脏高约10倍。肝脏和肝癌中合成酶II的分解代谢速率相似。因此,肝癌中合成酶II活性和含量的增加主要是由于酶生物合成速率的提高。有证据表明,在饥饿、糖尿病、重新喂食及给予胰岛素时,肝癌合成酶II的酶活性、含量及周转率几乎没有变化或没有变化。肝癌3924A合成酶II活性的周转率与正常肝脏酶在饥饿和糖尿病时的周转率之间的显著差异正在研究中。对肝脏和肝癌3924A中合成酶II的活性、含量及周转率行为的概述提供了证据,证明胰岛素在调节肝脏合成酶II中起重要作用,且肝癌酶对胰岛素浓度明显缺乏反应。实验程序和酶学结果的精确细节将在其他地方发表。